$BRO

Brown & Brown (NYSE:BRO) Misses Q2 CY2026 Revenue Estimates

Brown & Brown (NYSE:BRO) reported Q2 CY2026 revenue of $1.68 billion, up 30.4% year over year but below analysts’ $1.72 billion estimate. Non-GAAP EPS was $1.07, matching consensus. Adjusted EBITDA was $598 million versus $603.1 million expected. The article also notes analysts expect 12-month revenue growth of 5.9%.

Original reporting
Published Jul 27, 2026, 9:45 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 9:55 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Brown & Brown (NYSE:BRO) Misses Q2 CY2026 Revenue Estimates — source image
Decision brief

The 30-second read

$BRONeutralLow
01

Why it matters

The key new datapoints are the Q2 CY2026 revenue miss ($1.68B vs $1.72B) and adjusted EBITDA miss ($598M vs $603.1M), partially offset by adjusted EPS matching ($1.07).

02

Market read

Traders can reassess near-term expectations given the revenue and EBITDA misses, even though EPS was in line and YoY growth was strong.

03

What to watch

The article does not discuss guidance, deal flow, or segment performance; traders may need those details to judge whether the revenue miss reflects temporary timing versus structural slowdown.

Relevance 5/10Novelty 4/10Timing: after-hours/late-day reaction to Q2 CY2026 results

Background

Brown & Brown is an insurance brokerage and risk management firm; the article frames the quarter’s results versus Wall Street consensus.

Company-level read

Ticker impact

$BRONeutralMedium confidence
Context

Brown & Brown reported Q2 CY2026 revenue of $1.68B versus $1.72B estimates, while adjusted EPS of $1.07 matched consensus.

Expected impact

Likely choppy trading, with downside risk if investors focus on the revenue miss and EBITDA margin/EBITDA miss rather than EPS in-line.

Evidence & confidence

The article provides concrete print vs consensus (revenue and adjusted EBITDA) and notes EPS in-line, which typically dampens the reaction but still matters for brokerage valuation tied to growth and earnings quality.

Market effects

Signals insurance brokerage demand remains strong (30.4% YoY revenue growth) but with some deceleration versus recent pace.

No specific regional impact mentioned.

No explicit global macro or cross-border catalyst mentioned.

Counterpoint

The 30.4% YoY revenue growth and in-line adjusted EPS may indicate the miss is more about estimate expectations than deteriorating fundamentals.

Key entities

  • Brown & Brown

    Insurance brokerage reporting Q2 CY2026 results versus analyst consensus.

Related articles

$BROMed

Why Are Brown & Brown (BRO) Shares Soaring Today

Brown & Brown (NYSE: BRO) shares rose about 5% after the company reported Q2 results. Revenue increased 30.4% year over year to $1.68B, slightly below analysts’ $1.72B estimate. Adjusted EPS was $1.07, in line with expectations, driving investor focus on strong growth despite the revenue miss.

$BROMed

Brown & Brown Q2 Earnings Call Highlights

Brown & Brown (NYSE:BRO) discussed Q2 results on its earnings call. CFO Andy Watts said Retail revenue rose 35.9% mainly from acquisitions, while Retail organic growth was pressured by a pharmacy consulting business and a litigation-related organic revenue adjustment. Specialty Distribution total revenue rose 28.1% on Accession, with EBITDAC margin down to 42.7%. BRO expects H2 Retail organic growth excluding contingents of 1.5% to 2.5% and Specialty 2% to 4%, and reaffirmed $30M-$40M integratio

$BROMedAI 8/10

Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents

Brown & Brown, Inc. (NYSE:BRO) reported unaudited Q2 2026 results. Total revenues rose to $1.7 billion, up 30.4% year over year, while organic revenue fell 0.7%. Net income attributable to the company increased to $288 million, and diluted EPS was $0.84. For six months, revenues were $3.6 billion, up 33.0%.

$BROMedAI 8/10

BROWN & BROWN, INC. (BRO): Results of Operations and Financial Condition

BROWN & BROWN, INC. (BRO) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 bro-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Brown & Brown, Inc. announces second quarter 2026 results, including total revenues of $1.7 billion, an increase of 30.4%; Organic Revenue decrease of 0.7%; growth of Organic Revenue with Contingents of 0.7%; diluted net incom